Mahesh Patel Selected Research

zidebactam

1/2020	Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa.
1/2019	In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae.
1/2017	WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahesh Patel Research Topics

Disease

11	Infections 01/2022 - 07/2010
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2019
1	Albuminuria 12/2023
1	Human Influenza (Influenza) 01/2022
1	Phototoxic Dermatitis (Phototoxicity) 01/2022
1	Bradycardia 01/2022
1	Syncope (Fainting) 01/2022
1	Bronchogenic Cyst 03/2021
1	Weight Gain 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Non-alcoholic Fatty Liver Disease 03/2020
1	Alcoholic Fatty Liver 03/2020
1	Acute Lung Injury 01/2020
1	Wilms Tumor (Wilm's Tumor) 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Solitary Kidney 01/2016
1	HIV Infections (HIV Infection) 07/2010
1	Endocarditis 05/2008
1	Acute Coronary Syndrome 07/2005
1	Dehydration (Water Stress) 03/2005

Drug/Important Bio-Agent (IBA)

5	levonadifloxacinIBA 01/2022 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2005
3	LactamsIBA 10/2021 - 01/2017
3	cefepime-zidebactamIBA 10/2021 - 01/2020
3	zidebactamIBA 01/2020 - 01/2017
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2019
2	MacrolidesIBA 01/2022 - 01/2019
2	LipidsIBA 01/2021 - 07/2005
2	WCK 5153IBA 01/2019 - 01/2017
1	Angiotensin Receptor AntagonistsIBA 12/2023
1	SodiumIBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023
1	WCK 771IBA 01/2022
1	Levofloxacin (Levaquin)FDA Link 01/2022
1	WCK 1153IBA 01/2022
1	WCK 1152IBA 01/2022
1	Oxazolidinones (2 Oxazolidone)IBA 01/2022
1	Linezolid (Zyvox)FDA Link 01/2022
1	GlycopeptidesIBA 01/2022
1	ProdrugsIBA 12/2021
1	IntegrasesIBA 01/2021
1	Integrase InhibitorsIBA 01/2021
1	Glucagon (Glukagon)FDA Link 03/2020
1	FluoroquinolonesIBA 01/2020
1	Cefepime (Maxipime)FDA LinkGeneric 01/2020
1	LipopolysaccharidesIBA 01/2020
1	efavirenz (Sustiva)FDA Link 01/2016
1	CreatinineIBA 01/2016
1	Tenofovir (Viread)FDA Link 01/2016
1	Emtricitabine (Emtriva)FDA Link 01/2016
1	Immunoglobulin M (IgM)IBA 07/2010
1	Immunoglobulin G (IgG)IBA 07/2010
1	IceIBA 05/2008
1	TroponinIBA 05/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2005
1	Sch 725424IBA 03/2005
1	Sch 725428IBA 03/2005

Therapy/Procedure

1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Decompression 03/2021
1	Art Therapy 01/2021
1	Therapeutics 01/2021
1	Nephrectomy 01/2016
1	Drug Therapy (Chemotherapy) 01/2016
1	Highly Active Antiretroviral Therapy (HAART) 07/2010
1	Intraperitoneal Injections 07/2010
1	Transplantation 07/2010